PT  - JOURNAL ARTICLE
AU  - Mihaljevic, André L.
AU  - Dörr-Harim, Colette
AU  - Kalkum, Eva
AU  - Strunk, Guido
TI  - Measuring patient centeredness with German language Patient-Reported Experience Measures (PREM) – a systematic review and qualitative analysis according to COSMIN
AID  - 10.1101/2022.02.04.22270374
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.04.22270374
4099  - http://medrxiv.org/content/early/2022/02/06/2022.02.04.22270374.short
4100  - http://medrxiv.org/content/early/2022/02/06/2022.02.04.22270374.full
AB  - Background Patient centeredness is an integral part of the quality of care. Patient-reported experience measures (PREMs) are assumed to be an appropriate tool to assess patient-centredness. An evaluation of German-speaking PREMs is lacking.Objective To perform a systematic review and qualitative analysis of psychometric measurement qualities of German-speaking PREMs.Methods A systematic literature search was performed in Medline, PsycInfo, CINHAL, Embase, Cochrane database (last search 9th November 2021) for studies describing generic, surgery-or cancer-specific PREMs. Subsequently, questionnaires that were not in German or for which no German translation exists were excluded. Furthermore, questionnaires, that are for healthcare professionals rather than patients as well as disease-specific questionnaires were excluded. Baseline data for all studies was extracted by two independent reviewers. Psychometric measurement qualities of the questionnaires were assessed according to the COSMIN guidelines.Results In total, 3457 abstracts were screened, of which 3345 were excluded. The remaining 112 articles contained 51 PREMs, of which 12 were either developed in or translated into German: 8 generic (NORPEQ, PPE-15, PEACS, HCAHPS, QPPS, DUQUE, PEQ-G, Schoenfelder et al.), 4 cancer-specific (EORTC IN-PATSAT32, PSCC-G, Danish National Cancer Questionnaire, SCCC) and no surgery-specific PREM. None of the PREMs covered all 16 domains patient-centeredness. Overall rating of structural validity was adequate only for PEACS and HCAHPS. High ratings for internal consistency were given for NORPEQ, Schoenfelder et al., PSCC-G and the SCCC. Cross-cultural validity for translated questionnaires was adequate only for the PSCC-G, while reliability was adequately assessed only for the EORTC IN-PATSAT32. Due to a lack of measurement gold standard and minimal important change, criterion validity and measurement invariance could not be assessed Most PREMs showed the expected outcomes for hypotheses testing for construct validity.Conclusion None of the PREMs has been fully evaluated in German. Based on current evidence, the EORTC IN-PATSAT32 and PSCC-G can be recommended for cancer patients, while HCAHPS, NORPEQ, PPE-15 and PEACS might be used as generic PREMs. Compared to other languages PREM development in German is rudimentary and no comprehensive PREM system is currently available.Registration PROSPERO CRD42021276827Funding NoneCompeting Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/#searchadvanced Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files